Phibro Animal Health Corporation

NASDAQ PAHC

Download Data

Phibro Animal Health Corporation Price to Earnings Ratio (P/E) on June 03, 2024: 63.16

Phibro Animal Health Corporation Price to Earnings Ratio (P/E) is 63.16 on June 03, 2024, a 236.31% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.
  • Phibro Animal Health Corporation 52-week high Price to Earnings Ratio (P/E) is 65.35 on May 24, 2024, which is 3.46% above the current Price to Earnings Ratio (P/E).
  • Phibro Animal Health Corporation 52-week low Price to Earnings Ratio (P/E) is 11.28 on February 14, 2024, which is -82.14% below the current Price to Earnings Ratio (P/E).
  • Phibro Animal Health Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is 22.38.
NASDAQ: PAHC

Phibro Animal Health Corporation

CEO Mr. Jack Clifford Bendheim
IPO Date April 11, 2014
Location United States
Headquarters Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
Employees 1,920
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Similar companies

PROC

Procaps Group SA

NA

NA

EGRX

Eagle Pharmaceuticals Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email